ASSESSMENT OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Keywords:
Systemic lupus erythematosus, endothelial dysfunction, vascular endothelial growth factorAbstract
Currently, the determination of predictors of an unfavorable outcome of the disease is of great relevance, since they allow a more rational approach to the selection of more adequate therapy. Systemic lupus erythematosus (SLE) is a particularly significant problem in clinical rheumatology, since the survival rate of this group of patients remains very low. Therefore, all attempts aimed at finding predictors that affect life expectancy in a given disease are of leading importance and this is of practical interest. Pathology of the cardiovascular system, kidneys and central nervous system in SLE is one of the most frequent manifestations of the disease and largely determines its prognosis, and the pathogenetic structures of lesions of the myocardium, coronary, renal and cerebral vessels remain insufficiently studied.
References
Dessein, PH, Norton, GR, Woodiwiss, AJ e.a. Influence of nonclassical renal risk factors on the accuracy of predicting subclinical atherosclerosis in systemic lupus erythematosus // Rheumatol. 2007. Vol. 34. № 5. P. 943 – 591.
Dessein, PH, Tobias, M, Veller, MG. Metabolic syndrome and subclinical atherosclerosis in systemic lupus erythematosus //J Rheumatol. 2006. Vol. 33. № 12. P. 2425 – 2432.
DeyRao R. Genomewide transcriptional profiling data from chronic cutanous lupus erythematosus (CCLE)peripheral blood / R. DeyRao, A.A. Sinha // Data Brief. — 2014. — Vol. 11, № 2. — P. 3941.
Dhakal B.P., Kim C.H., Al-Kindi S.G., Oliveira G.H. (2017) Heart failure in systemic lupus erythematosus. Trends. Cardiovasc. Med., 6(9): 1050.
Ding Y. Association of miRNA‑145 expression in vascular smooth muscle cells with vascular damages in patients withlupus nephritis / Y. Ding, W. Liao, Z. Yi [et al.] // Int. J. Clin. Exp. Pathol. — 2015. — Vol. 8, № 10. — P. 1264612656.
Falasinnu T., Chaichian Y., Simard J.F. (2017) Impact of sex on systemic lupus erythematosus-related causes of premature mortality in the United States. J. Womens Health, 26(11): 1214–1221.
Ferrante A. Endothelial progenitor cells: Are they displaying a function in autoimmune disorders? // Mech. Ageing. Dev. — 2016. — Vol. 3, № 5. — P. 122128.
Frostegard, J. SLE, atherosclerosis and renal disease // J Intern Med. 2005. Vol. 257. № 6. P. 485 – 495.
Ge X.Y., Shao L., Zheng Z.L. (2016) Assessment right atrial function in patients with systemic lupus erythematosus by speckle tracking and three-dimensional echocardiography. Zhonghua Yi Xue Za Zhi, 96(47): 3815–3818.
Ghofraniha L., Mirfeizi Z., Khabbaz F.S. et al. (2017) Correlation of echocardiographic findings of pulmonary hypertension with six-minute walk test and plasma pro b-type natriuretic peptide level in systemic lupus erythematous. Electron Physician., 9(8): 5122–5128.
Guo L., Li M., Chen Y. et al. (2015) Anti-endothelin receptor type a autoantibodies in systemic lupus erythematosus. Arthritis Rheumatol., 67(9): 2394–2402.
Hurlimann, D, Enseleit, F, Ruschitzka, F. systemic lupus erythematosus, inflammation, and atherosclerosis // Rheumatol. 2004. Vol. 29. № 8. P. 760 – 768.
Iwasaki S. Fatal cardiac smallvessel involvement in ANCAassociated vasculitis: an autopsy case report // Cardiovasc. Pathol. — 2015. — Vol. 24, № 6. — P. 408410.
Jafri K., Ogdie A., Qasim A. et al. (2017) Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis. Clin. Rheumatol., 9(10): 203–209.
Lee S.W., Park M.C., Park Y.B., Lee S.K. (2012) E/E ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in systemic lupus erythematosus. Lupus, 17(3): 195–201.
Libby, P., Ridker, P.M., Maseri, A. Inflammation and atherosclerosis//Circulation. 2002. № 105. P. 1135 – 1143.
Liuzzo, G., Colussi, C., Ginnetti, F. e.a. C-reactive protein directly induces the activation of the transcription factor NFкВ in human monocytes: a clue to pathogenesis of nephrotic syndromes? // Eur. Ren J. 2001. № 22. P. 372.
Lima D.S., Liuzzo, G., Goronzy, J.J., Yang, H. e.a. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes // Circulation. 2000. № 101. P. 2883 – 2888.
Mak A., Kow N.Y., Schwarz H. et al. (2017) Endothelial dysfunction in systemic lupus erythematosus — a case-control study and an updated meta-analysis and meta-regression. Sci. Rep., 7(1): 7320.
Maksimowicz-McKinnon, K, Magder, LS, Petri, M. Predictors of carotid atherosclerosis in systemic lupus erythematosus // J Rheumatol. 2006. Vol. 33. № 12. P. 2458 – 2463.
Maradit-Kremers, Magadmi E.I., H, Crowson, CS, Nicola, PJ e.a. Increased unrecognized coronary heart disease and sudden deaths in systemic lupus
